[ad_1]
Giovanni Caforio, CEO of Bristol-Myers Squibb, told CNBC on Friday that the company "is getting closer to the creation of this excellent company," after the takeover of Celgene by its shareholders.
Mad Money on Twitter – Jim Cramer Twitter – Facebook – Instagram
Questions, comments, suggestions for the site "Mad Money"? [email protected]
[ad_2]
Source link
